NCT03026998View on ClinicalTrials.gov

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma (DepiSCARRH)

NAActive, not recruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

March 19, 2017

Primary Completion Date

March 31, 2034

Study Completion Date

March 31, 2034

Conditions
Hereditary Retinoblastoma
Interventions
PROCEDURE

MRI

MRI will be performed each year during 10 years.

Trial Locations (1)

75005

Institut Curie, Paris

All Listed Sponsors
lead

Institut Curie

OTHER